Stem cells injected into damaged hearts: a new hope?
NCT ID NCT05068674
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests whether injecting lab-grown heart cells (made from human embryonic stem cells) can safely improve heart function in 18 adults with chronic heart damage from a past heart attack. Participants receive one of three doses via a catheter, and researchers monitor safety and heart imaging for up to a year. The goal is to find a safe dose, not yet to cure the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC ISCHEMIC LEFT VENTRICULAR DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford Hospital and Clinics
RECRUITINGPalo Alto, California, 94305, United States